EPA DHA ALA (オメガ3)のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global EPA DHA ALA (Omega 3) Market Insights and Forecast to 2028

• レポートコード：QY2203B00564 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のEPA DHA ALA (オメガ3)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にEPA DHA ALA (オメガ3)の世界市場のxxx％を占める「フィッシュオイル」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「健康補助食品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のEPA DHA ALA (オメガ3)の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのEPA DHA ALA (オメガ3)市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのEPA DHA ALA (オメガ3)市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 EPA DHA ALA (オメガ3)のグローバル主要メーカーには、EPAX、Golden Omega、TASA、Omega Protein、Croda、KD Pharma、GC Rieber、Polaris、Auqiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 EPA DHA ALA (オメガ3)市場は、種類と用途によって区分されます。世界のEPA DHA ALA (オメガ3)市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 フィッシュオイル、アルゲオイル 【用途別セグメント】 健康補助食品、機能性食品・飲料、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - EPA DHA ALA (オメガ3)製品概要 - 種類別市場（フィッシュオイル、アルゲオイル） - 用途別市場（健康補助食品、機能性食品・飲料、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のEPA DHA ALA (オメガ3)販売量予測2017-2028 - 世界のEPA DHA ALA (オメガ3)売上予測2017-2028 - EPA DHA ALA (オメガ3)の地域別販売量 - EPA DHA ALA (オメガ3)の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別EPA DHA ALA (オメガ3)販売量 - 主要メーカー別EPA DHA ALA (オメガ3)売上 - 主要メーカー別EPA DHA ALA (オメガ3)価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（フィッシュオイル、アルゲオイル） - EPA DHA ALA (オメガ3)の種類別販売量 - EPA DHA ALA (オメガ3)の種類別売上 - EPA DHA ALA (オメガ3)の種類別価格 ・用途別市場規模（健康補助食品、機能性食品・飲料、その他） - EPA DHA ALA (オメガ3)の用途別販売量 - EPA DHA ALA (オメガ3)の用途別売上 - EPA DHA ALA (オメガ3)の用途別価格 ・北米市場 - 北米のEPA DHA ALA (オメガ3)市場規模（種類別、用途別） - 主要国別のEPA DHA ALA (オメガ3)市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのEPA DHA ALA (オメガ3)市場規模（種類別、用途別） - 主要国別のEPA DHA ALA (オメガ3)市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のEPA DHA ALA (オメガ3)市場規模（種類別、用途別） - 主要国別のEPA DHA ALA (オメガ3)市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のEPA DHA ALA (オメガ3)市場規模（種類別、用途別） - 主要国別のEPA DHA ALA (オメガ3)市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのEPA DHA ALA (オメガ3)市場規模（種類別、用途別） - 主要国別のEPA DHA ALA (オメガ3)市場規模（トルコ、サウジアラビア） ・企業情報 EPAX、Golden Omega、TASA、Omega Protein、Croda、KD Pharma、GC Rieber、Polaris、Auqi ・産業チェーン及び販売チャネル分析 - EPA DHA ALA (オメガ3)の産業チェーン分析 - EPA DHA ALA (オメガ3)の原材料 - EPA DHA ALA (オメガ3)の生産プロセス - EPA DHA ALA (オメガ3)の販売及びマーケティング - EPA DHA ALA (オメガ3)の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - EPA DHA ALA (オメガ3)の産業動向 - EPA DHA ALA (オメガ3)のマーケットドライバー - EPA DHA ALA (オメガ3)の課題 - EPA DHA ALA (オメガ3)の阻害要因 ・主な調査結果

Omega-3s are considered a healthy fat that is critical to our brain and heart function, as well as our overall well-being. 
Market Analysis and Insights: Global EPA DHA ALA (Omega 3) Market
Due to the COVID-19 pandemic, the global EPA DHA ALA (Omega 3) market size is estimated to be worth US$ 64500 million in 2022 and is forecast to a readjusted size of US$ 114140 million by 2028 with a CAGR of 10.0% during the review period. Fully considering the economic change by this health crisis, Fish Oil accounting for % of the EPA DHA ALA (Omega 3) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Dietary Supplements segment is altered to an % CAGR throughout this forecast period.
China EPA DHA ALA (Omega 3) market size is valued at US$ million in 2021, while the US and Europe EPA DHA ALA (Omega 3) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe EPA DHA ALA (Omega 3) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of EPA DHA ALA (Omega 3) include EPAX, Golden Omega, TASA, Omega Protein, Croda, KD Pharma, GC Rieber, Polaris and Auqi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global EPA DHA ALA (Omega 3) Scope and Segment
EPA DHA ALA (Omega 3) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global EPA DHA ALA (Omega 3) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Fish Oil
Algae Oil
Segment by Application
Dietary Supplements
Functional Foods & Beverages
Others
By Company
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma
GC Rieber
Polaris
Auqi
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 EPA DHA ALA (Omega 3) Product Introduction
1.2 Market by Type
1.2.1 Global EPA DHA ALA (Omega 3) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fish Oil
1.2.3 Algae Oil
1.3 Market by Application
1.3.1 Global EPA DHA ALA (Omega 3) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dietary Supplements
1.3.3 Functional Foods & Beverages
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global EPA DHA ALA (Omega 3) Sales Estimates and Forecasts 2017-2028
2.2 Global EPA DHA ALA (Omega 3) Revenue Estimates and Forecasts 2017-2028
2.3 Global EPA DHA ALA (Omega 3) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global EPA DHA ALA (Omega 3) Sales by Region
2.4.1 Global EPA DHA ALA (Omega 3) Sales by Region (2017-2022)
2.4.2 Global Sales EPA DHA ALA (Omega 3) by Region (2023-2028)
2.5 Global EPA DHA ALA (Omega 3) Revenue by Region
2.5.1 Global EPA DHA ALA (Omega 3) Revenue by Region (2017-2022)
2.5.2 Global EPA DHA ALA (Omega 3) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global EPA DHA ALA (Omega 3) Sales by Manufacturers
3.1.1 Global Top EPA DHA ALA (Omega 3) Manufacturers by Sales (2017-2022)
3.1.2 Global EPA DHA ALA (Omega 3) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of EPA DHA ALA (Omega 3) in 2021
3.2 Global EPA DHA ALA (Omega 3) Revenue by Manufacturers
3.2.1 Global EPA DHA ALA (Omega 3) Revenue by Manufacturers (2017-2022)
3.2.2 Global EPA DHA ALA (Omega 3) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by EPA DHA ALA (Omega 3) Revenue in 2021
3.3 Global EPA DHA ALA (Omega 3) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global EPA DHA ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global EPA DHA ALA (Omega 3) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global EPA DHA ALA (Omega 3) Sales by Type
4.1.1 Global EPA DHA ALA (Omega 3) Historical Sales by Type (2017-2022)
4.1.2 Global EPA DHA ALA (Omega 3) Forecasted Sales by Type (2023-2028)
4.1.3 Global EPA DHA ALA (Omega 3) Sales Market Share by Type (2017-2028)
4.2 Global EPA DHA ALA (Omega 3) Revenue by Type
4.2.1 Global EPA DHA ALA (Omega 3) Historical Revenue by Type (2017-2022)
4.2.2 Global EPA DHA ALA (Omega 3) Forecasted Revenue by Type (2023-2028)
4.2.3 Global EPA DHA ALA (Omega 3) Revenue Market Share by Type (2017-2028)
4.3 Global EPA DHA ALA (Omega 3) Price by Type
4.3.1 Global EPA DHA ALA (Omega 3) Price by Type (2017-2022)
4.3.2 Global EPA DHA ALA (Omega 3) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global EPA DHA ALA (Omega 3) Sales by Application
5.1.1 Global EPA DHA ALA (Omega 3) Historical Sales by Application (2017-2022)
5.1.2 Global EPA DHA ALA (Omega 3) Forecasted Sales by Application (2023-2028)
5.1.3 Global EPA DHA ALA (Omega 3) Sales Market Share by Application (2017-2028)
5.2 Global EPA DHA ALA (Omega 3) Revenue by Application
5.2.1 Global EPA DHA ALA (Omega 3) Historical Revenue by Application (2017-2022)
5.2.2 Global EPA DHA ALA (Omega 3) Forecasted Revenue by Application (2023-2028)
5.2.3 Global EPA DHA ALA (Omega 3) Revenue Market Share by Application (2017-2028)
5.3 Global EPA DHA ALA (Omega 3) Price by Application
5.3.1 Global EPA DHA ALA (Omega 3) Price by Application (2017-2022)
5.3.2 Global EPA DHA ALA (Omega 3) Price Forecast by Application (2023-2028)
6 North America
6.1 North America EPA DHA ALA (Omega 3) Market Size by Type
6.1.1 North America EPA DHA ALA (Omega 3) Sales by Type (2017-2028)
6.1.2 North America EPA DHA ALA (Omega 3) Revenue by Type (2017-2028)
6.2 North America EPA DHA ALA (Omega 3) Market Size by Application
6.2.1 North America EPA DHA ALA (Omega 3) Sales by Application (2017-2028)
6.2.2 North America EPA DHA ALA (Omega 3) Revenue by Application (2017-2028)
6.3 North America EPA DHA ALA (Omega 3) Market Size by Country
6.3.1 North America EPA DHA ALA (Omega 3) Sales by Country (2017-2028)
6.3.2 North America EPA DHA ALA (Omega 3) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe EPA DHA ALA (Omega 3) Market Size by Type
7.1.1 Europe EPA DHA ALA (Omega 3) Sales by Type (2017-2028)
7.1.2 Europe EPA DHA ALA (Omega 3) Revenue by Type (2017-2028)
7.2 Europe EPA DHA ALA (Omega 3) Market Size by Application
7.2.1 Europe EPA DHA ALA (Omega 3) Sales by Application (2017-2028)
7.2.2 Europe EPA DHA ALA (Omega 3) Revenue by Application (2017-2028)
7.3 Europe EPA DHA ALA (Omega 3) Market Size by Country
7.3.1 Europe EPA DHA ALA (Omega 3) Sales by Country (2017-2028)
7.3.2 Europe EPA DHA ALA (Omega 3) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific EPA DHA ALA (Omega 3) Market Size by Type
8.1.1 Asia Pacific EPA DHA ALA (Omega 3) Sales by Type (2017-2028)
8.1.2 Asia Pacific EPA DHA ALA (Omega 3) Revenue by Type (2017-2028)
8.2 Asia Pacific EPA DHA ALA (Omega 3) Market Size by Application
8.2.1 Asia Pacific EPA DHA ALA (Omega 3) Sales by Application (2017-2028)
8.2.2 Asia Pacific EPA DHA ALA (Omega 3) Revenue by Application (2017-2028)
8.3 Asia Pacific EPA DHA ALA (Omega 3) Market Size by Region
8.3.1 Asia Pacific EPA DHA ALA (Omega 3) Sales by Region (2017-2028)
8.3.2 Asia Pacific EPA DHA ALA (Omega 3) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America EPA DHA ALA (Omega 3) Market Size by Type
9.1.1 Latin America EPA DHA ALA (Omega 3) Sales by Type (2017-2028)
9.1.2 Latin America EPA DHA ALA (Omega 3) Revenue by Type (2017-2028)
9.2 Latin America EPA DHA ALA (Omega 3) Market Size by Application
9.2.1 Latin America EPA DHA ALA (Omega 3) Sales by Application (2017-2028)
9.2.2 Latin America EPA DHA ALA (Omega 3) Revenue by Application (2017-2028)
9.3 Latin America EPA DHA ALA (Omega 3) Market Size by Country
9.3.1 Latin America EPA DHA ALA (Omega 3) Sales by Country (2017-2028)
9.3.2 Latin America EPA DHA ALA (Omega 3) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa EPA DHA ALA (Omega 3) Market Size by Type
10.1.1 Middle East and Africa EPA DHA ALA (Omega 3) Sales by Type (2017-2028)
10.1.2 Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Type (2017-2028)
10.2 Middle East and Africa EPA DHA ALA (Omega 3) Market Size by Application
10.2.1 Middle East and Africa EPA DHA ALA (Omega 3) Sales by Application (2017-2028)
10.2.2 Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Application (2017-2028)
10.3 Middle East and Africa EPA DHA ALA (Omega 3) Market Size by Country
10.3.1 Middle East and Africa EPA DHA ALA (Omega 3) Sales by Country (2017-2028)
10.3.2 Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 EPAX
11.1.1 EPAX Corporation Information
11.1.2 EPAX Overview
11.1.3 EPAX EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 EPAX EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 EPAX Recent Developments
11.2 Golden Omega
11.2.1 Golden Omega Corporation Information
11.2.2 Golden Omega Overview
11.2.3 Golden Omega EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Golden Omega EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Golden Omega Recent Developments
11.3 TASA
11.3.1 TASA Corporation Information
11.3.2 TASA Overview
11.3.3 TASA EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 TASA EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 TASA Recent Developments
11.4 Omega Protein
11.4.1 Omega Protein Corporation Information
11.4.2 Omega Protein Overview
11.4.3 Omega Protein EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Omega Protein EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Omega Protein Recent Developments
11.5 Croda
11.5.1 Croda Corporation Information
11.5.2 Croda Overview
11.5.3 Croda EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Croda EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Croda Recent Developments
11.6 KD Pharma
11.6.1 KD Pharma Corporation Information
11.6.2 KD Pharma Overview
11.6.3 KD Pharma EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 KD Pharma EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 KD Pharma Recent Developments
11.7 GC Rieber
11.7.1 GC Rieber Corporation Information
11.7.2 GC Rieber Overview
11.7.3 GC Rieber EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GC Rieber EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GC Rieber Recent Developments
11.8 Polaris
11.8.1 Polaris Corporation Information
11.8.2 Polaris Overview
11.8.3 Polaris EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Polaris EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Polaris Recent Developments
11.9 Auqi
11.9.1 Auqi Corporation Information
11.9.2 Auqi Overview
11.9.3 Auqi EPA DHA ALA (Omega 3) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Auqi EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Auqi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 EPA DHA ALA (Omega 3) Industry Chain Analysis
12.2 EPA DHA ALA (Omega 3) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 EPA DHA ALA (Omega 3) Production Mode & Process
12.4 EPA DHA ALA (Omega 3) Sales and Marketing
12.4.1 EPA DHA ALA (Omega 3) Sales Channels
12.4.2 EPA DHA ALA (Omega 3) Distributors
12.5 EPA DHA ALA (Omega 3) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 EPA DHA ALA (Omega 3) Industry Trends
13.2 EPA DHA ALA (Omega 3) Market Drivers
13.3 EPA DHA ALA (Omega 3) Market Challenges
13.4 EPA DHA ALA (Omega 3) Market Restraints
14 Key Findings in The Global EPA DHA ALA (Omega 3) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global EPA DHA ALA (Omega 3) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Fish Oil
Table 3. Major Manufacturers of Algae Oil
Table 4. Global EPA DHA ALA (Omega 3) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global EPA DHA ALA (Omega 3) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global EPA DHA ALA (Omega 3) Sales by Region (2017-2022) & (K Units)
Table 7. Global EPA DHA ALA (Omega 3) Sales Market Share by Region (2017-2022)
Table 8. Global EPA DHA ALA (Omega 3) Sales by Region (2023-2028) & (K Units)
Table 9. Global EPA DHA ALA (Omega 3) Sales Market Share by Region (2023-2028)
Table 10. Global EPA DHA ALA (Omega 3) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global EPA DHA ALA (Omega 3) Revenue Market Share by Region (2017-2022)
Table 12. Global EPA DHA ALA (Omega 3) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global EPA DHA ALA (Omega 3) Revenue Market Share by Region (2023-2028)
Table 14. Global EPA DHA ALA (Omega 3) Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global EPA DHA ALA (Omega 3) Sales Share by Manufacturers (2017-2022)
Table 16. Global EPA DHA ALA (Omega 3) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global EPA DHA ALA (Omega 3) Revenue Share by Manufacturers (2017-2022)
Table 18. EPA DHA ALA (Omega 3) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global EPA DHA ALA (Omega 3) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global EPA DHA ALA (Omega 3) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EPA DHA ALA (Omega 3) as of 2021)
Table 21. EPA DHA ALA (Omega 3) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers EPA DHA ALA (Omega 3) Product Offered
Table 23. Date of Manufacturers Enter into EPA DHA ALA (Omega 3) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global EPA DHA ALA (Omega 3) Sales by Type (2017-2022) & (K Units)
Table 26. Global EPA DHA ALA (Omega 3) Sales by Type (2023-2028) & (K Units)
Table 27. Global EPA DHA ALA (Omega 3) Sales Share by Type (2017-2022)
Table 28. Global EPA DHA ALA (Omega 3) Sales Share by Type (2023-2028)
Table 29. Global EPA DHA ALA (Omega 3) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global EPA DHA ALA (Omega 3) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global EPA DHA ALA (Omega 3) Revenue Share by Type (2017-2022)
Table 32. Global EPA DHA ALA (Omega 3) Revenue Share by Type (2023-2028)
Table 33. EPA DHA ALA (Omega 3) Price by Type (2017-2022) & (US$/Unit)
Table 34. Global EPA DHA ALA (Omega 3) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global EPA DHA ALA (Omega 3) Sales by Application (2017-2022) & (K Units)
Table 36. Global EPA DHA ALA (Omega 3) Sales by Application (2023-2028) & (K Units)
Table 37. Global EPA DHA ALA (Omega 3) Sales Share by Application (2017-2022)
Table 38. Global EPA DHA ALA (Omega 3) Sales Share by Application (2023-2028)
Table 39. Global EPA DHA ALA (Omega 3) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global EPA DHA ALA (Omega 3) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global EPA DHA ALA (Omega 3) Revenue Share by Application (2017-2022)
Table 42. Global EPA DHA ALA (Omega 3) Revenue Share by Application (2023-2028)
Table 43. EPA DHA ALA (Omega 3) Price by Application (2017-2022) & (US$/Unit)
Table 44. Global EPA DHA ALA (Omega 3) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America EPA DHA ALA (Omega 3) Sales by Type (2017-2022) & (K Units)
Table 46. North America EPA DHA ALA (Omega 3) Sales by Type (2023-2028) & (K Units)
Table 47. North America EPA DHA ALA (Omega 3) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America EPA DHA ALA (Omega 3) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America EPA DHA ALA (Omega 3) Sales by Application (2017-2022) & (K Units)
Table 50. North America EPA DHA ALA (Omega 3) Sales by Application (2023-2028) & (K Units)
Table 51. North America EPA DHA ALA (Omega 3) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America EPA DHA ALA (Omega 3) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America EPA DHA ALA (Omega 3) Sales by Country (2017-2022) & (K Units)
Table 54. North America EPA DHA ALA (Omega 3) Sales by Country (2023-2028) & (K Units)
Table 55. North America EPA DHA ALA (Omega 3) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America EPA DHA ALA (Omega 3) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe EPA DHA ALA (Omega 3) Sales by Type (2017-2022) & (K Units)
Table 58. Europe EPA DHA ALA (Omega 3) Sales by Type (2023-2028) & (K Units)
Table 59. Europe EPA DHA ALA (Omega 3) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe EPA DHA ALA (Omega 3) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe EPA DHA ALA (Omega 3) Sales by Application (2017-2022) & (K Units)
Table 62. Europe EPA DHA ALA (Omega 3) Sales by Application (2023-2028) & (K Units)
Table 63. Europe EPA DHA ALA (Omega 3) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe EPA DHA ALA (Omega 3) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe EPA DHA ALA (Omega 3) Sales by Country (2017-2022) & (K Units)
Table 66. Europe EPA DHA ALA (Omega 3) Sales by Country (2023-2028) & (K Units)
Table 67. Europe EPA DHA ALA (Omega 3) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe EPA DHA ALA (Omega 3) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific EPA DHA ALA (Omega 3) Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific EPA DHA ALA (Omega 3) Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific EPA DHA ALA (Omega 3) Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific EPA DHA ALA (Omega 3) Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific EPA DHA ALA (Omega 3) Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific EPA DHA ALA (Omega 3) Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific EPA DHA ALA (Omega 3) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America EPA DHA ALA (Omega 3) Sales by Type (2017-2022) & (K Units)
Table 82. Latin America EPA DHA ALA (Omega 3) Sales by Type (2023-2028) & (K Units)
Table 83. Latin America EPA DHA ALA (Omega 3) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America EPA DHA ALA (Omega 3) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America EPA DHA ALA (Omega 3) Sales by Application (2017-2022) & (K Units)
Table 86. Latin America EPA DHA ALA (Omega 3) Sales by Application (2023-2028) & (K Units)
Table 87. Latin America EPA DHA ALA (Omega 3) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America EPA DHA ALA (Omega 3) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America EPA DHA ALA (Omega 3) Sales by Country (2017-2022) & (K Units)
Table 90. Latin America EPA DHA ALA (Omega 3) Sales by Country (2023-2028) & (K Units)
Table 91. Latin America EPA DHA ALA (Omega 3) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America EPA DHA ALA (Omega 3) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa EPA DHA ALA (Omega 3) Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa EPA DHA ALA (Omega 3) Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa EPA DHA ALA (Omega 3) Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa EPA DHA ALA (Omega 3) Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa EPA DHA ALA (Omega 3) Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa EPA DHA ALA (Omega 3) Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa EPA DHA ALA (Omega 3) Revenue by Country (2023-2028) & (US$ Million)
Table 105. EPAX Corporation Information
Table 106. EPAX Description and Major Businesses
Table 107. EPAX EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. EPAX EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. EPAX Recent Developments
Table 110. Golden Omega Corporation Information
Table 111. Golden Omega Description and Major Businesses
Table 112. Golden Omega EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Golden Omega EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Golden Omega Recent Developments
Table 115. TASA Corporation Information
Table 116. TASA Description and Major Businesses
Table 117. TASA EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. TASA EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. TASA Recent Developments
Table 120. Omega Protein Corporation Information
Table 121. Omega Protein Description and Major Businesses
Table 122. Omega Protein EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Omega Protein EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Omega Protein Recent Developments
Table 125. Croda Corporation Information
Table 126. Croda Description and Major Businesses
Table 127. Croda EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Croda EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Croda Recent Developments
Table 130. KD Pharma Corporation Information
Table 131. KD Pharma Description and Major Businesses
Table 132. KD Pharma EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. KD Pharma EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. KD Pharma Recent Developments
Table 135. GC Rieber Corporation Information
Table 136. GC Rieber Description and Major Businesses
Table 137. GC Rieber EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. GC Rieber EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. GC Rieber Recent Developments
Table 140. Polaris Corporation Information
Table 141. Polaris Description and Major Businesses
Table 142. Polaris EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Polaris EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Polaris Recent Developments
Table 145. Auqi Corporation Information
Table 146. Auqi Description and Major Businesses
Table 147. Auqi EPA DHA ALA (Omega 3) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Auqi EPA DHA ALA (Omega 3) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Auqi Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. EPA DHA ALA (Omega 3) Distributors List
Table 153. EPA DHA ALA (Omega 3) Customers List
Table 154. EPA DHA ALA (Omega 3) Market Trends
Table 155. EPA DHA ALA (Omega 3) Market Drivers
Table 156. EPA DHA ALA (Omega 3) Market Challenges
Table 157. EPA DHA ALA (Omega 3) Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. EPA DHA ALA (Omega 3) Product Picture
Figure 3. Global EPA DHA ALA (Omega 3) Market Share by Type in 2021 & 2028
Figure 3. Fish Oil Product Picture
Figure 4. Algae Oil Product Picture
Figure 5. Global EPA DHA ALA (Omega 3) Market Share by Application in 2021 & 2028
Figure 6. Dietary Supplements
Figure 7. Functional Foods & Beverages
Figure 8. Others
Figure 9. EPA DHA ALA (Omega 3) Report Years Considered
Figure 10. Global EPA DHA ALA (Omega 3) Sales 2017-2028 (K Units)
Figure 11. Global EPA DHA ALA (Omega 3) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global EPA DHA ALA (Omega 3) Revenue 2017-2028 (US$ Million)
Figure 13. Global EPA DHA ALA (Omega 3) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global EPA DHA ALA (Omega 3) Sales Market Share by Region (2017-2022)
Figure 15. Global EPA DHA ALA (Omega 3) Sales Market Share by Region (2023-2028)
Figure 16. North America EPA DHA ALA (Omega 3) Sales YoY (2017-2028) & (K Units)
Figure 17. North America EPA DHA ALA (Omega 3) Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe EPA DHA ALA (Omega 3) Sales YoY (2017-2028) & (K Units)
Figure 19. Europe EPA DHA ALA (Omega 3) Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific EPA DHA ALA (Omega 3) Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific EPA DHA ALA (Omega 3) Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America EPA DHA ALA (Omega 3) Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America EPA DHA ALA (Omega 3) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa EPA DHA ALA (Omega 3) Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa EPA DHA ALA (Omega 3) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The EPA DHA ALA (Omega 3) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of EPA DHA ALA (Omega 3) in the World: Market Share by EPA DHA ALA (Omega 3) Revenue in 2021
Figure 28. Global EPA DHA ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global EPA DHA ALA (Omega 3) Sales Market Share by Type (2017-2028)
Figure 30. Global EPA DHA ALA (Omega 3) Revenue Market Share by Type (2017-2028)
Figure 31. Global EPA DHA ALA (Omega 3) Sales Market Share by Application (2017-2028)
Figure 32. Global EPA DHA ALA (Omega 3) Revenue Market Share by Application (2017-2028)
Figure 33. North America EPA DHA ALA (Omega 3) Sales Market Share by Type (2017-2028)
Figure 34. North America EPA DHA ALA (Omega 3) Revenue Market Share by Type (2017-2028)
Figure 35. North America EPA DHA ALA (Omega 3) Sales Market Share by Application (2017-2028)
Figure 36. North America EPA DHA ALA (Omega 3) Revenue Market Share by Application (2017-2028)
Figure 37. North America EPA DHA ALA (Omega 3) Sales Share by Country (2017-2028)
Figure 38. North America EPA DHA ALA (Omega 3) Revenue Share by Country (2017-2028)
Figure 39. U.S. EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 40. Canada EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 41. Europe EPA DHA ALA (Omega 3) Sales Market Share by Type (2017-2028)
Figure 42. Europe EPA DHA ALA (Omega 3) Revenue Market Share by Type (2017-2028)
Figure 43. Europe EPA DHA ALA (Omega 3) Sales Market Share by Application (2017-2028)
Figure 44. Europe EPA DHA ALA (Omega 3) Revenue Market Share by Application (2017-2028)
Figure 45. Europe EPA DHA ALA (Omega 3) Sales Share by Country (2017-2028)
Figure 46. Europe EPA DHA ALA (Omega 3) Revenue Share by Country (2017-2028)
Figure 47. Germany EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 48. France EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 50. Italy EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 51. Russia EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific EPA DHA ALA (Omega 3) Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific EPA DHA ALA (Omega 3) Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific EPA DHA ALA (Omega 3) Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific EPA DHA ALA (Omega 3) Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific EPA DHA ALA (Omega 3) Sales Share by Region (2017-2028)
Figure 57. Asia Pacific EPA DHA ALA (Omega 3) Revenue Share by Region (2017-2028)
Figure 58. China EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 59. Japan EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 61. India EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 62. Australia EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America EPA DHA ALA (Omega 3) Sales Market Share by Type (2017-2028)
Figure 69. Latin America EPA DHA ALA (Omega 3) Revenue Market Share by Type (2017-2028)
Figure 70. Latin America EPA DHA ALA (Omega 3) Sales Market Share by Application (2017-2028)
Figure 71. Latin America EPA DHA ALA (Omega 3) Revenue Market Share by Application (2017-2028)
Figure 72. Latin America EPA DHA ALA (Omega 3) Sales Share by Country (2017-2028)
Figure 73. Latin America EPA DHA ALA (Omega 3) Revenue Share by Country (2017-2028)
Figure 74. Mexico EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa EPA DHA ALA (Omega 3) Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa EPA DHA ALA (Omega 3) Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa EPA DHA ALA (Omega 3) Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa EPA DHA ALA (Omega 3) Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa EPA DHA ALA (Omega 3) Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa EPA DHA ALA (Omega 3) Revenue Share by Country (2017-2028)
Figure 83. Turkey EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 85. UAE EPA DHA ALA (Omega 3) Revenue (2017-2028) & (US$ Million)
Figure 86. EPA DHA ALA (Omega 3) Value Chain
Figure 87. EPA DHA ALA (Omega 3) Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---